1887

Abstract

Chequerboard and time–kill methods were used to compare the efficacies of the combinations gatifloxacin (GAT) with cefoperazone (CFP) and GAT with cefoperazone–sulbactam (CFP-SUL) against 58 clinical isolates of . The combinations GAT+CFP and GAT+CFP-SUL were shown to be synergistic for 36.2 and 58.6 % of isolates tested, respectively, using the chequerboard method. Time–kill studies with 11 strains showed synergy in 54.5 % for the GAT+CFP combination and 72.7 % for the GAT+CFP-SUL combination. The agreement between these two methods was found to be 72–81 %. There was a significant difference in synergy between the two combinations tested (=0.011).

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.2008/001636-0
2008-12-01
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/12/1514.html?itemId=/content/journal/jmm/10.1099/jmm.0.2008/001636-0&mimeType=html&fmt=ahah

References

  1. Bajaksouzian, S., Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. ( 1996; ). Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time–kill methods. Antimicrob Agents Chemother 40, 1973–1976.
    [Google Scholar]
  2. Dawis, M. A., Isenberg, H. D., France, K. A. & Jenkins, S. G. ( 2003; ). In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms. J Antimicrob Chemother 51, 1203–1211.[CrossRef]
    [Google Scholar]
  3. Eliopoulos, G. M. & Moellering, R. C., Jr ( 1991; ). Laboratory methods used to assess the activity of antimicrobial combinations. In Antibiotics in Laboratory Medicine, 3rd edn, pp. 432–492. Edited by V. Lorian. Baltimore, MD: Williams & Wilkins.
  4. Fish, D. N., Choi, M. K. & Jung, R. ( 2002; ). Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs. J Antimicrob Chemother 50, 1045–1049.[CrossRef]
    [Google Scholar]
  5. Gradelski, E., Valera, L., Bonner, D. & Fung-Tomc, J. ( 2001; ). Synergistic activities of gatifloxacin in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species. Antimicrob Agents Chemother 45, 3220–3222.[CrossRef]
    [Google Scholar]
  6. Mayer, I. & Nagy, E. ( 1999; ). Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp. J Antimicrob Chemother 43, 651–657.[CrossRef]
    [Google Scholar]
  7. CLSI ( 1999; ). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th edn, approved standard M7–A5. Wayne, PA: Clinical and Laboratory Standards Institute.
  8. CLSI ( 2000; ). Performance Standards for Antimicrobial Disk Susceptibility Test, approved standard M7–A5. Wayne, PA: Clinical and Laboratory Standards Institute.
  9. Neu, H. C. & Chin, N. X. ( 1994; ). In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob Agents Chemother 38, 2615–2622.[CrossRef]
    [Google Scholar]
  10. Pankey, G. A. & Ashcraft, D. S. ( 2005; ). In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 49, 2959–2964.[CrossRef]
    [Google Scholar]
  11. PDR ( 2004; ). Physicians' Desk Reference, 58th edn. Montvale, NJ: Thomsons.
  12. Rossolini, G. M. & Mantengoli, E. ( 2005; ). Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 11 (Suppl. 4), 17–32.
    [Google Scholar]
  13. Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. ( 1998; ). Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time–kill methodology. Antimicrob Agents Chemother 42, 953–955.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.2008/001636-0
Loading
/content/journal/jmm/10.1099/jmm.0.2008/001636-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error